Stay up to date on healthcare news, stories and insights from across the MATTER community.
Jul 19, 2019
As CEO of gene therapy pioneer AveXis, Sean Nolan helped shatter the record for Chicago-area biotech acquisitions — three times over — when he facilitated the 2018 sale of the company to Novartis for almost $9 billion. In his time at AveXis, Sean grew the team to more than 400 people, took the company public and quintupled its stock value. Sean’s journey in healthcare, however, began all the wa...
Read more